Argi Investment Services, LLC Gilead Sciences, Inc. Transaction History

Argi Investment Services, LLC

$1.18 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$62.32 - $89.47 $73,849 - $106,021	1,185 Added 0.96%	124,739 $10.7 Million
Q3 2022 Oct 20, 2022	BUY	$59.54 - $68.01 $376,769 - $430,367	6,328 Added 5.4%	123,554 $7.62 Million
Q2 2022 Jul 26, 2022	BUY	$57.72 - $65.01 $771,023 - $868,403	13,358 Added 12.86%	117,226 $7.25 Million
Q1 2022 Apr 27, 2022	BUY	$57.92 - $72.58 $1.29 Million - $1.61 Million	22,210 Added 27.2%	103,868 $6.18 Million
Q4 2021 Jan 28, 2022	BUY	$64.88 - $73.64 $414,583 - $470,559	6,390 Added 8.49%	81,658 $5.93 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $320,715 - $346,016	4,738 Added 6.72%	75,268 $5.26 Million
Q2 2021 Aug 03, 2021	BUY	$63.47 - $69.35 $272,540 - $297,788	4,294 Added 6.48%	70,530 $4.86 Million
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $2.5 Million - $2.85 Million	41,697 Added 169.92%	66,236 $4.28 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $40,164 - $45,765	-709 Reduced 2.81%	24,539 $1.43 Million
Q3 2020 Nov 04, 2020	SELL	$62.1 - $78.08 $108,923 - $136,952	-1,754 Reduced 6.5%	25,248 $1.6 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $2.45 Million - $2.85 Million	-33,931 Reduced 55.69%	27,002 $2.08 Million
Q1 2020 May 11, 2020	SELL	$62.63 - $80.22 $7,265 - $9,305	-116 Reduced 0.19%	60,933 $4.56 Million
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $2.76 Million - $3.03 Million	44,724 Added 273.96%	61,049 $4.2 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $30,567 - $33,741	489 Added 3.09%	16,325 $1.04 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $10,579 - $11,863	171 Added 1.09%	15,836 $1.07 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $66,844 - $74,883	1,069 Added 7.32%	15,665 $1.02 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $90,325 - $117,868	1,492 Added 11.39%	14,596 $913,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $617,213 - $683,368	-8,659 Reduced 39.79%	13,104 $1.01 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $17,387 - $20,282	268 Added 1.25%	21,763 $0
Q1 2018 May 04, 2018	BUY	$72.84 - $88.8 $755,423 - $920,944	10,371 Added 93.23%	21,495 $1.62 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $27,250 - $31,988	383 Added 3.57%	11,124 $797,000
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $196,499 - $232,905	-2,725 Reduced 20.24%	10,741 $869,000
Q2 2017 Aug 08, 2017	BUY	N/A	13,466	13,466 $953,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argi Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argi Investment Services, LLC with notifications on news.

Account